Companies / Colombia
Colombia Updates Reimbursement List
July 2006 | Industry NewsColombia's pharmaceutical reimbursement framework, the CNSSS, is to offer around 20 new APIs in 30 presentations. The mainly generic products include new therapies for cancer, HIV/AIDS, and other chronic diseases. Officials admit that an increase in the standard US$160 annual per-patient payment will be necessary to account for the new
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
